化学制药板块11月13日涨2.22%，富祥药业领涨，主力资金净流入3.09亿元

Group 1 - The chemical pharmaceutical sector increased by 2.22% on November 13, with Fuxiang Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] - Fuxiang Pharmaceutical's stock price rose by 20.03% to 17.50, with a trading volume of 526,500 shares and a transaction value of 9.17 billion [1] Group 2 - The main capital inflow in the chemical pharmaceutical sector was 309 million, while retail investors experienced a net outflow of 11.16 million [2] - The stock performance of several companies showed declines, with Xiangdi Pharmaceutical down 3.87% to 14.90 and Duorui Pharmaceutical down 3.51% to 55.76 [2] - The trading volume for the sector was significant, with Asia-Pacific Pharmaceutical recording a volume of 1.69 million shares and a transaction value of 1.45 billion [2] Group 3 - Major net inflows were observed in companies like XinNuoWei with 108 million and Fuxiang Pharmaceutical with 97.43 million, while retail investors showed significant outflows [3] - The net inflow for XinNuoWei represented 12.57% of its trading volume, indicating strong institutional interest [3] - The overall market sentiment reflected a mixed performance, with some companies like Changshan Pharmaceutical showing a net inflow of 71.81 million [3]